Regulation of glucose metabolism by incretins: implications for treatment of type 2 diabetes

被引：0
|
作者：
Saito, Rie [1 ]
Harada, Norio [1 ]
机构：
[1] Univ Fukui, Sch Med Sci, Dept Endocrinol & Metab, 23-3 Matsuoka Shimoaizuki,Eiheiji Cho, Fukui 9101193, Japan
来源：
DIABETOLOGY INTERNATIONAL | 2024年
关键词：
Incretin; GIP; GLP-1; Incretin effect; Insulin secretion; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; NON-ASIANS; SECRETION; TOLERANCE; MELLITUS; EFFICACY; GLP-1; GIP;
D O I：
10.1007/s13340-024-00781-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gastrointestinal hormones that potentiate insulin secretion from pancreatic beta-cells are called incretins. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the major incretins. Incretin-mediated stimulation of insulin secretion (incretin effect) plays an important role in lowering postprandial blood-glucose levels. Incretin effect is reduced under diabetic condition. Several mechanisms have been reported for the reduction of incretin effect. Incretin-related drugs are used worldwide for the treatment of type 2 diabetes. In addition, several new incretin-related drugs have been developed and are expected to be available in clinical practice.
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Mealtime glucose regulation in type 2 diabetes
    Tuomilehto, J
    Del Prato, S
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2001, 55 (06) : 380 - 383
  • [22] Physiological role of incretins: perspectives of treatment of patients with type 2 diabetes mellitus
    Galstyan, G. R.
    DIABETES MELLITUS, 2006, 9 (04): : 14 - 18
  • [23] Changes in Glucose Metabolism and Incretins before and 1 year after a Gastric Bypass Surgery in morbidly obese Patients with Type 2 Diabetes
    Svehlikova, Eva
    Schultes, Bernd
    Ernst, Barbara
    Freisinger, Oana
    Tadler, Friedrich
    Pieber, Thomas R.
    WIENER KLINISCHE WOCHENSCHRIFT, 2012, 124 : 15 - 15
  • [24] The physiology and pharmacology of incretins in type 2 diabetes mellitus
    Holst, Jens J.
    DIABETES OBESITY & METABOLISM, 2008, 10 : 14 - 21
  • [25] Incretins, insulin secretion and Type 2 diabetes mellitus
    Vilsboll, T
    Holst, JJ
    DIABETOLOGIA, 2004, 47 (03) : 357 - 366
  • [26] Incretins, a new strategy to treat type 2 diabetes
    Tan, Kimny
    Pillon, Francois
    ACTUALITES PHARMACEUTIQUES, 2009, 48 (481): : 21 - 22
  • [27] Incretins as new therapeutic targets of type 2 diabetes
    Puig-Domingo, M.
    Reviriego, J.
    REVISTA CLINICA ESPANOLA, 2007, 207 (07): : 352 - 364
  • [28] Incretins and cardiovascular disease: to the heart of type 2 diabetes?
    Solini, Anna
    Trico, Domenico
    Del Prato, Stefano
    DIABETOLOGIA, 2023, 66 (10) : 1820 - 1831
  • [29] Caffeine impairs glucose metabolism in type 2 diabetes
    Lane, J
    Barkauskas, C
    Surwit, R
    Feinglos, M
    DIABETES, 2003, 52 : A570 - A570
  • [30] Evaluation of glucose metabolism in type 2 diabetes mellitus
    Davydov, AL
    Starkova, NT
    Mayevsky, EI
    Zyakun, AN
    Sokolov, EI
    DIABETOLOGIA, 2001, 44 : A205 - A205
12345